A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Eli Lilly and Company
Elevation Oncology
Washington University School of Medicine
pharmaand GmbH
Stanford University
National Institutes of Health Clinical Center (CC)
Centre Leon Berard
National Institutes of Health Clinical Center (CC)
Stanford University